New nitroglycerin formulations: transdermal and transmucosal nitroglycerin.
D000284:Administration, Oral; D000287:Administration, Topical; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D009061:Mouth Mucosa / Q000378:metabolism; D005996:Nitroglycerin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D005996:Nitroglycerin